Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 2Thrombosis 1Supratentorial Brain Tumor 1Pain, Postoperative 1Ovarian Neoplasms 1Inflammation 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Arthritis, Rheumatoid 1Anemia 1

Interventions

toripalimab 1aldesleukin 1Saline Solution 1Gemcitabine 1Fluid Therapy 1Cytological Techniques 1Cystoscopy 1Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Carcinoma, Transitional Cell × Saline Solution × Clear all
NCT03062059 2022-04-14

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

National Cancer Center, Korea

Phase 2 Unknown
134 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡